Article Details

Canopy's latest acquisition target is a bit peculiar

Retrieved on: 2018-03-13 19:15:00

Tags for this article:

Click the tags to see associated articles and topics

Canopy's latest acquisition target is a bit peculiar. View article details on hiswai:

Excerpt

<div>According to a recent report from Bloomberg, <b>Canopy Growth</b> is one of the final three suitors -- along with U.K. healthcare investor GHO Capital and Spanish investment <b>company</b> Alantra Partners -- to acquire Spain's Alcaliber, a 45-year-old pharmaceutical <b>company</b> that manufactures and sells morphine ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up